1. Home
  2. BVFL vs NNNN Comparison

BVFL vs NNNN Comparison

Compare BVFL & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BVFL

BV Financial Inc.

SELL

Current Price

$21.38

Market Cap

178.8M

Sector

Finance

ML Signal

SELL

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$3.90

Market Cap

154.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BVFL
NNNN
Founded
1873
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.8M
154.1M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
BVFL
NNNN
Price
$21.38
$3.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.4K
★ 44.3K
Earning Date
10-23-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.19
N/A
EPS
★ 0.97
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $38.65
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$16.37
$3.09
52 Week High
$22.70
$44.73

Technical Indicators

Market Signals
Indicator
BVFL
NNNN
Relative Strength Index (RSI) 44.07 47.12
Support Level $20.36 $3.21
Resistance Level $21.86 $4.43
Average True Range (ATR) 0.48 0.35
MACD -0.11 0.13
Stochastic Oscillator 16.78 58.45

Price Performance

Historical Comparison
BVFL
NNNN

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: